This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Enantis S.r.o., Masarykova Univerzita. Active years: 2023.
Company Filing History:
1 out of 1 
1 out of 15 Years Active: 2023
Title: Zaneta Konecna: Innovator in Cell Biology and Regenerative Medicine
Introduction
Zaneta Konecna is a prominent inventor based in Pardubice, Czech Republic. She has made significant contributions to the fields of cell biology and regenerative medicine. Her innovative work has led to the development of a unique polypeptide that holds promise for various medical applications.
Latest Patents
Zaneta Konecna holds a patent for a thermostable FGF2 polypeptide, which is isolated and possesses FGF2 activity. This polypeptide has at least 85% sequence identity to SEQ ID NO: 2 (FGF2 wt) or a functional fragment thereof. The invention includes at least one amino acid substitution, R31L, and its applications extend to cell biology research, regenerative medicine, and cosmetics. Additionally, her patent discloses a culture medium that includes the subjected FGF2, suitable for culturing human pluripotent stem cells, including both human embryonic stem cells and induced pluripotent stem cells.
Career Highlights
Throughout her career, Zaneta has worked with notable institutions, including Masaryk University and Enantis s.r.o. Her work has been instrumental in advancing research in her field, showcasing her dedication to innovation and scientific progress.
Collaborations
Zaneta has collaborated with esteemed colleagues such as Pavel Krejci and Lukas Balek. These partnerships have further enriched her research and contributed to her success as an inventor.
Conclusion
Zaneta Konecna is a trailblazer in the realm of cell biology and regenerative medicine. Her patented innovations reflect her commitment to advancing scientific knowledge and improving medical applications.